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Abstract The neurotrophin receptor (NTR) and tumor necrosis 
factor receptor family of receptors regulate apoptotic cell death 
during development and in adult tissues [Beutler and van Huffel, 
Science 264 (1994) 667-668]. We have examined a fragment of 
p75NTR from the carboxyl terminus of the receptor and a 
variant form of this peptide via NMR techniques and in vitro 
assays for apoptotic activity. The wild type peptide induces 
apoptosis and adopts a helical conformation oriented parallel to 
the surface of lipid micelles, whereas the variant form adopts a 
non-helical conformation in the presence of lipid and shows no 
activity. These experiments suggest a link between structure and 
function of the two peptides. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The neurotrophin receptor gp75NTR (NTR) is a member 
of a receptor superfamily that mediates cell survival, pro-
grammed cell death and cell differentiation in the immune 
and nervous systems [1]. Activation of NTR in the absence 
of a neurotrophin ligand induces programmed cell death in 
neurons and other cell types [2-4]. Increased expression of 
NTR has been associated with apoptosis in neurons [2] and 
increased sensitivity to the toxicity of ß-amyloid peptide [4], a 
peptide which accumulates in the brains of patients of Alz-
heimer's disease [5]. Paradoxically, during embryonic develop-
ment NGF binding appears to activate rather than block the 
death of function of NTR [6]. 
NTR, like TNFR (55 kDa), DR3, and DR4 and Fas, in-
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duces programmed cell death [7-10]. NTR has a sequence 
motif of 80-100 amino acid residues in its cytoplasmic tail 
which is homologous to 'death domains' found in Fas and 
TNFR-I [11]. In the case of Fas, DR3, DR4 and TNFR-1, 
signals resulting in programmed cell death (apoptosis) appear 
to be transmitted through protein-protein interactions involv-
ing this 'death domain' [9,10,12-14]. Activation of these re-
ceptors leads to recruitment of proteins involved in cell signal-
ing to the plasma membrane [9,10,14]. The structure of the 
death domain of Fas has been recently reported [15]. 
Previous evaluation of structure-function relationships in 
the 'death domain' have concentrated on the residues having 
charged side chains (summarized in Huang et al. [15]). How-
ever, a potentially important hydrophobic surface is formed 
by helices five and six in the Fas death domain structure. The 
homologue of helix five in NTR is a peptide previously noted 
to contain homology to the wasp venom peptide mastoparan 
[11]. Mastoparan is a 14 residue peptide capable of activating 
heterotrimeric G-proteins, whose biological activity correlates 
with its ability to form an amphiphilic helix [16,17]. Further-
more mastoparan has been shown to induce apoptosis, both 
in whole cells [18] and in a cell-free system of apoptosis [19]. 
The homology of helix five to mastoparan suggested that an 
oe-helical conformation within this region of the death domain 
of NTR may be a requirement for induction of apoptosis. To 
test the hypothesis that an a-helical segment forms part of an 
interface between NTR and the death signaling machinery, we 
have analyzed the structure of a 14 residue peptide from the 
human receptor using nuclear magnetic resonance (NMR), 
and a variant form of this peptide. We have also carried 
out in vitro assays for apoptotic activity in neuronal precursor 
cells on these peptides. 
We have investigated the helix forming propensity of a 
peptide derived from NTR corresponding to residues 368-
381 of the human receptor (NTR368) and a lysine variant 
of NTR368 (L373K). The choice of this analog (L373K) 
was based on the observation that a mastoparan variant hav-
ing Lys instead of Leu at position 6 was both resistant to helix 
formation in l-palmitoyl-l,2-oleoylphosphatidylcholine and 
unable to stimulate GDP/GTP exchange by God protein 
[16]. NTR368 and mastoparan (Rabizadeh et al., submitted 
for publication) are potent inducers of neural apoptosis. We 
have also carried out in vitro assays which show that L373K 
does not induce neural apoptosis. The NMR studies demon-
strate that NTR368 forms a helical structure in the presence 
of micellar lipid. These studies have also shown L373K does 
not have the ability to form a helical structure. 
We have identified the optimal conditions for the NTR368 
structure determination experiments and have found them to 
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be with a lipid:peptide of 9 :1 , consistent with conditions for 
dynorphin A [20]. Additionally, we have carried out N M R 
N O E S Y experiments at higher lipid concentration with a lip-
id: peptide of 50:1 . These spectra were identical to the lower 
lipid concentration experiments; however, the line widths 
were broader. Thus, structural characterization was primarily 
carried out on the lower lipid concentration sample. We have 
carried out chemical shift indexing (CSI) which indicated that 
NTR368 has helical content. This is an ideal system for in-
vestigating the use of CSI with peptides bound to micelles, 
because we have a single amino acid mutat ion which does not 
adopt helical conformation as a control. Temperature coeffi-
cients were calculated that suggest solvent protection of one 
side of the helix. Finally, N M R studies using the nitroxide 
spin label, 12-doxyl stearate, show that the long helical axis 
of the peptide NTR368 is oriented parallel to the surface of 
the micelle and verify results suggested by the temperature 
coefficients. 
Because of the difficulties involved with N M R structure 
determination in the presence of lipid, there are few published 
structures of peptides in the presence of micelles. Typically 
line widths are severely line broadened, V1/2 approximately 
15-20 Hz, making the determination of coupling constants 
impossible by homonuclear methods. The recently reported 
model of dynorphin A [21] and structure of magainin [22] 
are of superior quality and advance this area of structure 
determination. Most studies [23,24] have been carried out at 
higher lipid concentrations. Our studies have been carried out 
with a lower lipid concentration and have resulted in a com-
parable number of constraints, 6.8 inter-residue N O E con-
straints per amino acid. 
These studies will lay the groundwork for investigations of 
the mechanism of induction of apoptosis in neurons, as well 
as, further characterization of the interactions between pep-
tides and lipid interfaces. 
2. Materials and methods 
2.1. Peptide synthesis 
A peptide was designed to represent the mastoparan homology 
found in residues 368-381 of human NTR [11]. This sequence is 
identical to rat NTR residues 365-378. The 14 residue sequence 
(ATLDALLAALRRIQ) was synthesized using standard scale Fmoc 
chemistry on an Applied Biosystems 430A automated synthesizer. The 
peptide (NTR368) was amino terminally acetylated and carboxy ter-
minally amidated. A variant of this peptide (ATLDAKLAALRRIQ), 
representing a Lys substitution at residue 373 of human NTR, was 
also prepared. These peptides were cleaved from resin with trifluoro-
acetic acid in the presence of ethanedithiol and anisóle, then purified 
by reversed phase HPLC on a Vydac semi-prep Qg column. Purity 
and molecular mass were verified by analytical HPLC and liquid 
secondary ion mass spectroscopy. 
Two additional HPLC-purified peptides were purchased from Coast 
Scientific (San Diego, CA) for functional studies in tissue culture. A 
26 residue peptide, containing the sequence of human NTR 367-380 
(corresponding to rat NTR 364-377), was designed with 12 amino 
acid residues of the human immunodeficiency virus (HIV) tat protein, 
GRKKRRQRRRPP, at its amino terminus. The tat protein sequence 
improves the efficiency of peptide entry into cells [25]. The masses of 
taí-ATLDALLAALRRIQ (taí-NTR368) and a Lys substitution var-
iant (ίαί-ATLDAKLAALRRIQ) called toi-NTR368-L373K were 
verified by mass spectroscopy. 
2.2. Cell culture and peptide application 
SH-SY-5Y (SH-SY) human neuroblastoma cells were grown and 
maintained in DMEM supplemented with 10% fetal bovine serum 
(FBS). For assays, SH-SY cells were plated onto 96-well plates. The 
peptides te!-NTR368 and í«í-NTR368-L373K were dissolved in water 
and diluted to 50 and 100 μΜ in serum free medium (SFM). Once 
diluted in SFM, the peptides were directly applied to the SH-SY cells 
in 96-well plates. After incubating for 18 h at 37°C, propidium iodide 
(20 μΜ) was added to the cells and cell viability was assessed in a 
Cytofluor fluorometric plate reader as described earlier [26]. 
2.3. NMR sample preparation 
Three NMR samples were prepared. Two samples contained 
NTR368 at low and high lipid concentration. A third NMR sample 
was prepared containing a peptide identical to the NTR368 peptide 
except for a single amino acid substitution (L373K). The lipid used in 
these studies, dodecylphosphocholine-d3g (DODPC), purchased from 
Cambridge Isotope Laboratory (Andover, MA), was solubilized in 
H 2 0 to a concentration of 630 mg/ml by heating to 60°C and agitat-
ing with a vortex until clear and used as a stock solution for the 
addition of lipid to the NMR samples. 
In the first sample, 8.0 mg of NTR368 was solubilized in 90 μΐ D 2 0 
and 510 μΐ H 2 0 . A 1.0 M NaCl solution was used to make the sample 
49 mM NaCl. DODPC and pH titrations were performed using a 
total of 30 μΐ of the DODPC stock solution and microliter amounts 
of 0.3 M NaOH and HC1, respectively. Conditions for optimal line 
widths and chemical shift dispersion for the low lipid concentration 
were found to be 7.7 mM NTR368, 69 mM DODPC, pH 5.2, and 49 
mM NaCl. 
In the second sample, 8.0 mg of NTR368 was solubilized in 70 μΐ 
D 2 0 and 600 μΐ H 2 0 . The 1.0 M NaCl stock solution was used to 
give a final NaCl concentration of 52 mM. Titrations of the lipid and 
pH were not performed on this sample, instead the pH was adjusted 
to 5.2, and 106 mg of DODPC was added to the sample. The con-
centrations of the second sample were 8.1 mM NTR368, 405 mM 
DODPC, pH 5.2, and 52 mM NaCl. 
The third sample contained the lysine variant form of the NTR 
fragment, L373K. This sample was prepared by first dissolving 4.0 
mg of the L373K peptide in 70 μΐ D 2 0 and 420 μΐ Η 2 0 . The sample 
was then titrated with the stock DODPC solution in 10 μΐ increments 
to a total of 40 μΐ of the stock DODPC. A pH titration was also 
performed using the 0.3 M NaOH and HC1 solutions. One-dimen-
sional NMR spectra were used to examine the effects of the titrants. 
The conditions of optimal line widths and chemical shift dispersion 
were at pH 5.0, 4.9 mM L373K, and 118 mM DODPC. To confirm 
that the peptide was saturated with DODPC, more lipid was added 
beyond the concentration where chemical shifts remained constant 
and NMR experiments were repeated with similar results. 
Finally, 3 μΐ of a 1.5 M stock solution of 12-doxyl stearic acid 
(purchased from Sigma) in rf-chloroform was added to the NTR368 
sample containing 405 mM DODPC. This yields a 60:1 ratio between 
DODPC:spin label. 
2.4. NMR data collection 
Proton NMR spectra were collected on Varían Unity 300 and 
Unity-plus 500 spectrometers operating at 300 and 500 MHz, respec-
tively. The chemical shifts were measured relative to sodium 2,2-di-
methyl-2-silapentane-5-sulfonate (DSS), used as an external reference. 
During data collection, the temperature was held at 25°C unless oth-
erwise specified. All data were collected in the phase sensitive mode 
[27]. The spectra showed no contamination in the lipid as previously 
reported [20]. 
Two-dimensional DQF-COSY [28], TOCSY [29] and NOESY 
[30,31] experiments were carried out on the low lipid concentration 
sample at both 300 and 500 MHz. Water suppression was performed 
by use of presaturation coupled with a Hahn echo for narrowing of 
the H 2 0 resonance for the TOCSY and by the use of jump-and-return 
read pulse [32] for the NOESY. Water suppression was enhanced 
through zero frequency subtraction of the time domain [33]. The 
mixing times were 50 ms for the TOCSY and 150 ms for the NOESY. 
Two-dimensional NOESY spectra were also taken at 75, 100, and 125 
ms in order to obtain a build up curve. This build up curve showed no 
spin-diffusion effects. There were a total of 512 measurements with 64 
transients for each measurement taken at 500 MHz and a total of 600 
measurements with 48 transients for each measurement taken at 300 
MHz. At both 300 and 500 MHz, 4096 data points for t2 were taken. 
Spectral widths for 300 and 500 MHz data collection were 4000 and 
6000 Hz, respectively. Experiments with the spin label sample had 
sweep widths of 8000 Hz in the direct dimension and 6250 Hz in 
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the indirect dimension. The time-domain data were multiplied by 
gaussian multiplier functions in the direct dimension and a skewed 
squared sine bell function in the indirect dimension. For all data, the 
final processed matrices were 2048 by 2048 points in the frequency 
domain. 
Two-dimensional TOCSY and NOESY experiments were run on 
both the high lipid concentration of NTR and the L373K peptide 
at 300 MHz, as described above at 25°C and 3°C. For both samples 
there were 4096 data points for t2 taken, and spectral widths were 
both 4000 Hz. 
2.5. Temperature coefficients and chemical shift indexing 
TOCSY and NOESY spectra were collected on the low and high 
lipid concentration samples of NTR368 as described above at 3°C, 
5°C, 16°C, 20°C, 25°C and 35°C. The amide proton chemical shifts 
were recorded and the temperature coefficients were calculated and 
recorded in parts per billion (ppb/°C). Chemical shift indexing was 
carried out as previously outlined [34]. The binary code, —1, 0 or +1 
was recorded for a-proton chemical shifts. These experiments were 
also used as controls to verify exchange conditions of the peptide 
between free and micelle-bound forms. 
2.6. Structure calculations 
NOE constraint distances were assigned as previously described 
[35]. Structure calculations were carried out with the XPLOR 3.1 
software package (Briinger, 1989) using the simulated annealing pro-
tocol [36,37]. Initial structures were generated with random coil ge-
ometry. Additionally, 11 initial structures were generated with uncon-
strained dynamics starting with unique random seed numbers. These 
structures were used to generate 90 annealed structures. Structures 
were subjected to a round of simulated annealing with backbone 
NOEs and then later again with side chain NOE constraints. These 
structures were minimized with a steepest descents and then conjugate 
gradient algorithm. The resulting structures were grouped into fami-
lies and then evaluated for root mean square deviations (rmsd) and 
noe constraint violations. 
3. Results 
3.1. Biological effects of NTR368 and NTR368-L373K 
The application of millimolar quantities of NTR367 to SH-
SY medium resulted in cell death. Addition of the same con-
centrations of NTR367-L373K to SH-SY medium showed 
little or no effect on cell viability (data not shown). This 
suggested a relationship between the primary structure of 
100-, 
90-
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Fig. 1. Death induced by ia!-NTR368 and not by ia!-NTR368-
L373K peptides in SH-SY cells. SH-SY cells were plated onto 96-
well plates and were placed on SFM with either ia/-NTR368 or tat-
NTR368-L373K. Death was induced when SH-SY cells were placed 
in either 50 μΜ or 100 μΜ of íaí-NTR368 (black) whereas the cells 
were unaffected by the toi-NTR368-L373K peptide (gray) as well as 
unsupplemented SFM (white). These data represent a single experi-
ment in which each condition was applied and assessed in quadru-
plicates. Error bars represent standard deviations. 
Table 1 
Chemical shifts of NTR368 
Residue 
Al 
T2 
L3 
D4 
A5 
L6 
L7 
A8 
A9 
L10 
R l l 
R12 
113 
Q14 
NH 
8.51 
9.24 
7.87 
7.94 
8.05 
8.33 
7.99 
7.81 
8.18 
8.08 
7.69 
7.75 
7.85 
a 
4.24 
4.13 
4.02 
4.27 
4.20 
4.05 
3.98 
4.06 
4.07 
3.99 
4.05 
4.14 
3.89 
4.07 
ß 
1.19 
4.24 
1.69 
2.68 
1.51 
1.79 
1.81 
1.48 
1.53 
1.82 
1.91 
1.99 
1.99 
2.05 
2.10 
Ί 
1.19 
1.54 
1.75 
1.58 
1.65 
1.74 
1.61 
1.23 
0.93 
2.31 
2.42 
Other 
δι-0.97 
Ö2-1.00 
δι-0.83 
Ö2-0.87 
δ!-0.90 
δ2-0.84 
δ!-0.82 
δ2-0.84 
δι-3.18 
Ö2-3.13 
ΝΗ-7.36 
δ-3.22 
ΝΗ-7.50 
δ-0.84 
Proton chemical shifts (ppm) of 7.7 mM NTR in H2O in the presence 
of 69 mM DODPC and 49 mM NaCl at pH 5.2 and 25°C. 
the peptides and function. To insure that the biological effects 
of these two peptides were not the result of the NTR367 
peptide's preferential ability to cross the cell membrane, a 
peptide from the HIV tat protein was attached to the peptide 
sequences. The ia£-NTR368 fusion peptide affected toxicity in 
SH-SY cells. At concentrations exceeding 50 μΜ, toí-NTR368 
induced greater than 97% cell death (Fig. 1). At the same 
concentration, iaZ-NTR368-L373K affected little toxicity rela-
tive to the absence of peptides. These results demonstrate that 
the difference in peptide effects is not due to a difference in 
membrane permeability and suggest that the region of the 
NTR corresponding to NTR368 may be involved in the re-
ceptor's ability to induce apoptosis. Moreover, the structural 
integrity of this region may determine its specificity for action 
and seems necessary to render its effects on neurons. 
Having established that the two similar peptides had diver-
gent biological activities, we looked to the three-dimensional 
structures for correlation. Because the peptides are small and 
flexible in solution, NMR structural studies were carried out 
in the presence of micellar lipid. The lipid provides a nuclea-
tion site for structure. We believe the function in the cell may 
be mediated either via protein:protein interactions or pro-
tein: lipid interactions. 
3.2. NMR spectral assignment of resonances 
Proton resonances of the low lipid concentration sample of 
NTR368 were identified by classical methods outlined by Wü-
thrich [38]. Spin systems were assigned by combination of 
DQF-COSY and TOCSY spectra (see Table 1). Sequential 
assignments were elucidated via comparison of TOCSY and 
NOESY spectra in the fingerprint region. Most helpful in the 
sequential assignments, were the intense dNN cross peaks. 
Spectra were acquired at 25°C and 35°C to resolve spectral 
overlap. Remaining ambiguities were resolved upon acquisi-
tion and analysis of the data at 500 MHz. The : H resonance 
assignments are listed in Table 1. 
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Fig. 2. Expansion of the amide section of a processed 150 ms mix-
ing time 300 MHz NOESY acquired at 25°C. The spectra are from 
samples containing (A) 7.7 mM NTR368, 69 mM DODPC, 49 mM 
NaCl at pH 5.2, (B) 8.1 mM NTR368, 405 mM DODPC, 52 mM 
NaCl at pH 5.2 and (C) 4.9 mM L373K, 118 mM DODPC at pH 
5.0. The spectra of NTR368 under conditions of high (B) and low 
(A) lipid concentrations are virtually identical. In contrast, these 
two spectra are markedly different from the NOESY of the peptide 
with a single leucine to lysine substitution in the sequence (C). 
3.3. Comparison of high and low lipid concentration 
The series of experiments carried out on the samples con-
taining NTR368 clearly demonstrate that this peptide adopts 
a well-defined structure that is stable over a wide range of 
lipid concentrations (Figs. 2 and 3). Previous reports of pep-
tide conformations have had substantially higher concentra-
tions of DODPC [23,39] and other types of lipid [24,40], or 
have been carried out in fast exchange with vesicles [41]. Our 
studies indicate that the peptide adopts its structure at a lip-
id: peptide ratio of 9:1, and maintains this structure through-
out the addition of DODPC to a lipid:peptide ratio of 50:1. 
This is in agreement with studies of peptides of this size pre-
viously reported [20]. The expansion of the amide region of 
NOESY spectra in Fig. 2, sections A and B, show that the 
peptide has the same chemical shifts and identical sequential 
connectivities under low and high lipid concentration. Inspec-
tion of Fig. 3 demonstrates that the fingerprint region and the 
amide, side chain regions of the NOESY spectra are virtually 
identical under these conditions as well. Minor differences in 
the spectra can be accounted for by the increase in line widths 
in the NTR368 sample containing 50:1 excess of DODPC. 
The line widths in the 50:1 lipid:peptide ratio sample and 
9:1 lipid:peptide were 20 Hz and 15 Hz, respectively. Because 
of the narrower line widths, the lower concentration of lipid 
was used for data collection at 500 MHz and identification of 
NOE cross peaks. The quality of the data is illustrated in an 
expanded fingerprint region of a NOESY spectrum collected 
at 500 MHz field strength (Fig. 4). 
3.4. Comparison of NTR368 and L373K spectra 
In contrast to concentration of DODPC, a single amino 
acid substitution (L373K) in the NTR368 peptide has a pro-
found influence on the peptide's structure in the presence of 
the micellar lipid. The 2D NOESY spectrum of L373K dem-
onstrates that the peptide has either random coil or extended 
conformation. The absence of sequential dNN connectivities 
in the NMR NOESY experiments for the L373K peptide 
show that it does not form the same structure as the 
NTR368 peptide (Fig. 2C). CSI data also suggest that the 
peptide is random coil (Fig. 5). There is an absence of chem-
ical shift dispersion which was observed in the other two 
NTR368 spectra (Fig. 2A,B), indicating that the L373K pep-
tide adopts a non-helical conformation. NOE cross peaks in 
the amide, side chain region of the NOESY spectra suggest 
that the change in peptide binds to the micelle and adopts a 
non-helical structure. Without peptide association to the mi-
celle, there would be very weak intensity NOE cross peaks 
because of the short correlation time of a peptide of this size. 
3.5. Conformational analysis of NTR368 
The secondary structural elements of the NTR368 peptide 
were elucidated primarily through analysis of the backbone 
NOEs. A summary of the backbone NOEs is shown in Fig. 6. 
A total of 103 NOEs were incorporated into structure calcu-
lations, including 23 i,i+2 NOEs and 32 NOEs between amino 
acids separated by three or more residues. The large line 
widths of the peptide prevent elucidation of dihedral angle 
constraints from DQF-COSY spectra. 
The NOEs observed for this peptide were highly consistent 
with the conformation of an a-helix. There are 11 dNN cross 
peaks which are of medium intensity and 1 dNN cross peak 
with weak intensity. There are a total of six dNN (i,i+2) cross 
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Fig. 3. Expansion of the amide, side chain section of 150 ms mixing time 300 MHz NOESY spectra from (A) a sample containing 7.7 mM 
NTR368, 69 mM DODPC, 49 mM NaCl at pH 5.2 and (B) 8.1 mM NTR368, 405 mM DODPC, 52 mM NaCl at pH 5.2. The spectra illus-
trate the extent to which the two sample conditions yield a peptide of identical conformation. 
peaks which have been observed. Additionally there are two 
dNN (i,i+3) cross peaks observed at the amino terminal end 
of the peptide. 
There are dccN NOE cross peaks which support that 
NTR368 adopts a helical structure. At the amino terminus 
there are four dccN (i,i+2) cross peaks and at the carboxyl 
terminus there are two dccN (i,i+2) cross peaks. The five docN 
(i,i+3) cross peaks are distributed throughout the peptide; 
however, there are four dccN (i,i+4) cross peaks, all of which 
extend from the amino terminus. 
The greater number of backbone helical NOEs at the amino 
terminus can be partially attributed to spectral overlap which 
prevents observation of these signals at the carboxyl terminus. 
This is illustrated by the presence of unfilled bars in Fig. 6 
which denotes cross peaks which cannot be observed due to 
spectral overlap. However, the presence of the longest range 
dNN and daN cross peaks exclusively at the amino terminus, 
suggests that the amino terminus of NTR368 forms a tighter 
helix than the carboxyl terminus which contains three consec-
utive bulky side chains, R l l , R12 and 113. 
The NOE constraints are generally equally distributed 
throughout NTR368. This is demonstrated in Fig. 5B which 
shows a graph of amino acid residue versus the number of 
NOE constraints which involve that amino acid. There are 
four alanines and four leucines in this 14 amino acid peptide. 
Chemical shift overlap in the side chains among the alanines 
and among the leucines provided the greatest hurdle in the 
structure determination. 
The amino acids with the greatest number of NOEs gener-
ally have signals with the greatest chemical shift dispersion in 
the peptide. Asp4 has the greatest number of constraints with 
22 NOEs. Asp4 has downfield shifted a and ß proton reso-
nances, which facilitate NOE elucidation. Thr2, with 20 con-
straints, is another example of a residue with unique chemical 
shifts which enable elucidation of a greater number of NOEs. 
At 25°C, Arg11 had many NOEs between its side chain and 
Ala8, as well as Gin14. We suspected this was due to confor-
mational exchange or perhaps spin diffusion effects. In NO-
ESY experiments of the sample containing a low concentra-
tion of DODPC at 3°C, we found that the NOEs to Gin14 
were no longer present. We did not include the NOEs between 
Arg11 and Gin14 in the structure calculations. We believe that 
there was significant flexibility in the side chains which was 
reduced at 3°C. 
Typical patterns of NOEs indicative of helical conformation 
are found throughout the peptide, but are concentrated near 
the amino terminus and the middle of the peptide. A large 
number of backbone i,i+3 cross peaks are observed from 
Fig. 4. This expansion of the fingerprint region of a 500 MHz 
NOESY spectrum collected at 25°C, 7.7 mM NTR368, 69 mM 
DODPC, 49 mM NaCl at pH 5.2 illustrates the quality of the data 
collected. With four leucines and four alanines in the peptide there 
is considerable overlap of signals in the α-proton dimension. 
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Asp4. Fig. 6B illustrates the central residues which show a 
large number of backbone i,i+3 cross peaks, though there is 
not a wealth of total number of NOEs due to either short 
length of the side chains or spectral overlap. 
3.6. Chemical shift indexing 
The chemical shift of 'H and 13C signals is affected by their 
location in secondary structure. Thus, we have also analyzed 
the conformation of NTR368 with CSI of oc-protons for fur-
ther confirmation of the helical structure in NTR368 [34]. For 
comparison, we indexed the NTR368 as well as L373K, the 
lysine variant form which does not show propensity to form 
an oc-helix in the presence of lipid. The CSI results in — 1 for 
binary code for all amides in NTR368 with the exception of 
He13. The CSI for L373K was more randomly distributed, 
some 0 and —1 throughout the peptide. This supports our 
conclusion that NTR368 is helical and that L373K is not. It 
is also an example of CSI calculations on a small peptide in a 
lipid environment which is in agreement with NOESY data. 
3.7. Temperature coefficients 
Temperature coefficients were calculated from the slopes of 
chemical shift vs. temperature for the amide protons in 
NTR368. The calculations were carried out for both the low 
and high lipid concentration samples. The coefficients did not 
indicate the expected amide proton protection from solvent as 
a result of hydrogen bonding (Fig. 6). The temperature coef-
ficients for the sample with low DODPC concentration are 
generally higher. This is expected because the sample with 
higher DODPC concentration will have a higher degree of 
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14 
Gin 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Ala Thr Leu Asp Ala | Lys | Leu Ala Ala Leu Arg Arg j | e (j]n 
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RESIDUE NUMBER 
Fig. 5. A: The results of the CSI data for (top) NTR368, 7.7 mM 
NTR368, 69 mM DODPC, 49 mM NaCl at pH 5.2 and (bottom) 
for L373K, 4.9 mM L373K, 1118 mM DODPC at pH 5.O. The re-
sults indicate that NTR368 has chemical shifts for α-protons of an 
ce-helical conformation while the α-proton signals of L373K sample 
exhibit random coil chemical shifts. B: A plot of the number of in-
ter-residue NOE constraints per amino acid. This graph illustrates 
the extent and distribution of the NOE data. The top illustrates the 
distribution of i,i+3 and i,i+4 NOEs and (bottom) total number of 
NOEs. Note that each inter-residue NOE will appear two times in 
each section. 
A T L DA L L A A L R R I Q 
Λχ/ΛΤ high 7 3 9 7 5 7 7 7 7 6 7 6 7 
low 8 4 9 7 4 7 8 8 6 7 7 6 7 dNN 
daN 
dNN(i,i+2) 
dNN(i,i+3) 
daN(i,i+2) 
daN(i,i+3) 
daN(i,i+4) 
Fig. 6. NOE connectivities observed for 7.7 mM NTR in the pres-
ence of 69 mM DODPC and 50 mM NaCl, pH 5.2. The thickness 
of bars indicates strong, medium and weak NOEs with the thickest 
bars indicating strongest NOEs. Open bars indicate NOEs that can-
not be observed due to spectral overlap. The top two rows of num-
bers are temperature coefficients in parts per billion for the two pep-
tide samples containing high (8.1 mM NTR368, 405 mM DODPC, 
52 mM NaCl at pH 5.2) and low (7.7 mM NTR368, 69 mM 
DODPC, 49 mM NaCl at pH 5.2) lipid concentrations. 
peptide saturation of micelles. Interestingly, we noted lower 
temperature coefficients in both samples for Leu3 and Leu6 
(Fig. 6). We note that Leu10 on the low lipid sample and 
Arg11 in the high lipid sample and He13 have temperature 
coefficients lower than their neighboring amino acids. Inde-
pendently, the structure calculations show that Leu3, Leu6, 
Leu10 and He13 are all on the same side of the a-helix. The 
fluctuations in the temperature coefficients suggest that the 
micelle is protecting one face of the a-helix from solvent ex-
posure. We note that these residues are all strongly hydro-
phobic. The lower temperature coefficients clustered at the 
N-terminus of the helix is in agreement with NOE data and 
suggests that this terminus of the peptide forms a tighter helix. 
This may be a result of tighter association with the micelle 
interface, or an intrinsic property of the peptide. 
Table 2 
Effect of spin label on NTR368 
Residue NH-aH 
Al 
T2 
L3 
D4 
A5 
L6 
L7 
A8 
A9 
L10 
Rll 
R12 
113 
Q14 
0 
0 
82 
10 
0 
0 
12 
0 
0 
7 
16 
6 
100 
23 
5 
0 
28 
23 
0 
44 
22 
0 
31 
40 
16 
18 
% of 1H NMR signal remaining in TOCSY spectra in the presence of 
12-doxyl stearic acid. 
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Fig. 7. TOCSY experiments were carried out in the presence (A and C) and in the absence (B and D) of the spin label, 12-doxyl stearic acid. 
The experiments were carried out at 3°C, where conformational fluctuations in the carboxyl terminus of the peptide are at a minimum. The di-
minished signals indicate protons which are buried in the lipid environment of the DODPC micelle. 
3.8. Experiments with 12-doxyl stearic acid 
We were interested in further determination of the orienta-
tion of this peptide with respect to the surface of the micelle. 
We suspected it would be oriented parallel to the surface even 
though the sequence does not suggest this peptide is a true 
amphipathic helix. Towards this goal, 12-doxyl stearic acid 
(12-dox) was added to the NMR sample containing high con-
centration of DODPC. 12-dox carries an unpaired electron on 
the twelfth carbon of this fatty acid, thus positioning a free 
radical toward the center of the micelle. It has been shown 
previously (Brown, 1981 #5; Brown, 1982 #6) that 12-dox 
partitions into DODPC micelles and out of the aqueous en-
vironment. The unpaired electron provides an additional re-
laxation pathway for nearby protons and severely line broad-
ens the NMR signals. In this case, signals of protons buried in 
the micelle will be diminished or eliminated upon addition of 
12-dox. 
As expected, the data show that the peptide is oriented 
parallel to the micelle surface with the leucines buried in the 
nonpolar environment. The results of the TOCSY experiment 
at 3°C (see Fig. 7A-D) summarized in Table 2 are in agree-
ment with the temperature coefficient studies. Most signals 
were affected by the spin label, indicating a high degree of 
insertion of the peptide into the micelle. There are periodic 
fluctuations in the degree that ΧΗ signals were affected by the 
spin label, corresponding to the helical conformation of 
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NTR368. The fingerprint region signals (Fig. 7C,D) of Asp4, 
Ala5, Ala8 and the carboxyl terminal residues Argn-Gln1 4 
were least affected. These protons are in the aqueous environ-
ment. Similar trends were noted in the α,β proton cross peaks 
of the TOCSY. The NH, a cross peak of Gin14 retained 100% 
of its previous intensity. 
The leucine residues serve as a hydrophobic anchor of 
NTR368 as evidenced by the omission of all the four leucine 
signals in the fingerprint region and the α,β cross peak region 
(see Fig. 7A,B). These data also demonstrate an increase in 
surface exposure at the carboxyl end of the peptide. This is 
consistent with observations that the carboxyl end of the pep-
tide exhibits mobility at room temperature. 
3.9. Structure calculations 
The results of structure calculations show the NTR368 pep-
tide in helical conformation through the first 10 amino acids. 
The first round of simulated annealing calculations does not 
include side chain NOEs from Arg11 and Arg12. The struc-
tures from these calculations result in helical conformation 
over the entire span of the peptide. These structures were 
then subjected to simulated annealing including the side chain 
NOE constraints from Arg11 and Arg12. The result is an un-
winding of the helix over the last four amino acids of the 
peptide. 
The structure calculations yielded three families of struc-
tures, the largest family contained 17 structures. A superposi-
tion of this family is shown in Fig. 8D. The greatest consistent 
Table 3 
Agreement among NTR368 structures 
Fig. 8. The backbone atoms of a sample low energy structure of the 
NTR368 peptide, (A) shown from the side and (B) looking down 
the axis of the helix and (C) with the side chains of Leu3, Leu6 and 
Leu10 shown. These are three amino acids with depressed tempera-
ture coefficients for their amide proton signals. Finally, (D) an over-
lay of 10 structures from a family of 17 structures. Three families 
of structures were calculated. This family contained the lowest num-
ber of NOE violations. The calculations were based on constraints 
from NOESY spectra in the presence of DODPC micelles; however, 
calculations are carried out in a vacuum without lipid present. 
Residue 
Al 
T2 
L3 
D4 
A5 
L6 
L7 
A8 
A9 
L10 
R l l 
R12 
113 
Q14 
Residues 1-14 
2.5 
1.5 
1.2 
1.0 
1.2 
1.2 
1.2 
1.7 
2.7 
1.4 
1.7 
2.1 
2.5 
3.7 
Residues 1-10 
0.7 
0.3 
0.3 
0.3 
0.4 
0.5 
0.5 
0.6 
0.6 
1.8 
Rmsd (A) of backbone atoms for 17 structures of family 1 of NTR368 
based on alignments. 
NOE violation (1.3 Á) is from Asp4 ßH to Leu6 δΗ. The rmsd 
of the backbone atoms within this family of structures was 1.8 
A. A second alignment of the NTR368 structures was carried 
out over the first 10 residues of the peptide. With this align-
ment, the backbone rmsd of the first 10 residues was 0.6 A. 
Finally, residues 11-14 were aligned to assess if there is a 
hinge in the peptide across which NOE data cannot link the 
structures. The rmsd of the last four amino acids of NTR368 
is 1.32 A. A summary of these alignments is shown in Table 3. 
4. Discussion 
Biochemical experiments have shown that addition of 
NTR368 to the media for neural cells induces apoptosis or 
cell death, while the addition of the same peptide with a single 
substitution, L373K, does not. The NMR studies demonstrate 
that NTR368 has helix forming propensity that is abolished 
by the single substitution in L373K, supporting one explan-
ation for how this single amino acid substitution can have 
such a profound effect on the induction of the apoptotic path-
way. Further studies to elucidate minimal components of this 
peptide for induction of apoptosis and corresponding NMR 
determinations of peptide conformation are being undertaken. 
The helical structure of NTR368 in the presence of DODPC 
micelles spans from residues 1 to 10. These results support the 
model previously proposed [11] which predict the structure of 
NTR368 to be α-helical. After Leu10, it is not clear to what 
extent the structure maintains an a-helical structure through 
the carboxyl terminus of the peptide. The absence of amide, 
amide long distance NOEs in this region of the peptide indi-
cates a likely deviation from a-helical structure. 
NTR368 is oriented parallel to the surface of the micelle, 
with a greater degree of peptide insertion in the middle resi-
dues (Ala5-Leu10). The residues of the helix which face the 
aqueous environment correspond to the amino acids Ala1, 
Asp4, Ala8, Arg12 and Gin14. NTR368 is not a true amphi-
pathic helix, in that the entire middle of the peptide lacks a 
polar residue (sequence ALL AAL). NMR studies of peptide 
models of transmembrane spanning helices generally contain 
large numbers of alanines and leucines flanked by the posi-
tively charged amino acid, lysine. Such studies have been car-
ried out with SDS as the lipid. SDS, which is negatively 
charged, has a favorable interaction with lysine while the ala-
nines and leucines are inserted in the hydrophobic portion of 
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the micelles. NTR368 is insoluble in SDS and not long 
enough to allow the peptide to span a membrane or a 
DODPC micelle. Rather it interacts with the surface. We 
have identified the amino acids in the sequence which are 
most buried in the micellar lipid. These residues are Leu3, 
Leu6, Leu7 and Leu10. Therefore peptide:lipid interactions 
are dominated by leucines. 
Examination of the structures of the NTR368 peptide in the 
presence of DODPC micelles shows why L373K cannot form 
an amphipathic or membrane spanning-type a-helix. The po-
sition of lysine in L373K is on the side of the helix which 
contains entirely hydrophobic amino acids. Leu3 and Leu10 
are also on this side of the helix, which face the micellar sur-
face. Therefore, Leu6 (now Lys6) is also in a position which 
the temperature coefficients and spin label data suggest to be 
facing the micelle surface. Both of these factors would con-
tribute to disruption of the a-helix. 
The quality of the structures has been hampered by the 
omission of hydrogen bonding constraints and dihedral angle 
constraints. We have attempted unsuccessfully to identify sol-
vent protection of the amide hydrogens by measuring cou-
pling constants and temperature coefficients. We have ob-
tained NOE data 2D NOESY experiments from a variety of 
conditions. The next step for structure determination on a 
higher level of resolution is to isotopically label the peptide 
and carry out Ή - 1 5 Ν HMQC-J and NOESY 3D 15N isotopi-
cally filtered experiments. 
The sample conditions used for these experiments also illus-
trate that there is no rule for lipid:peptide ratios for NMR 
experiments. The optimal conditions for structural character-
ization of a peptide in the presence of micelles is dependent 
upon the individual system, peptide and type of lipid. We 
have noted that peptides larger than 20 amino acids or pep-
tides which are inserted integrally into membranes require 
higher lipid concentrations [24] such that the micelle:peptide 
ratio is approximately 1:1. There are disadvantages to using 
higher lipid concentrations. The aggregation number of the 
micelles increases with lipid concentration [20], resulting in 
increased line widths. 
The reporting of the structure of the Fas (APO-1/CD95) 
death domain has given us an opportunity to consider how 
this peptide functions to induce apoptosis. NTR368 corre-
sponds to helix five of the NMR-determined structure of the 
Fas domain [15]. The homology between these regions of Fas 
and NTR [44] would place this peptide in helix five of the 
NTR death domain as well. Huang et al. [15] noted a hydro-
phobic patch on the surface of Fas was formed by helices five 
and six. Interestingly, a reported sequence alignment [11] 
shows that the corresponding hydrophobic patch in NTR 
would be even larger than that which is found in Fas. Accord-
ing to the sequence alignment by Chapman [11], two of the 
charged surface residues in Fas, Lys272 and Asp273, corre-
spond to Ala375 and Ala376 of NTR. The Fas structure studies 
reported that alanine substitutions in the hydrophobic patch 
did not affect oligomerization of Fas or its interaction with 
FADD, its downstream signaling protein. These substitutions 
have focused on the electrostatic interactions via polar resi-
dues, lysine, aspartic acid and threonine. We postulate that 
function of the peptide, NTR368, requires the maintenance of 
the hydrophobic surface of this helix and that a disruption of 
this surface prevents NTR368 from interacting with the death 
machinery. The hydrophobic surface may serve to orient the 
hydrophilic side of the helix toward death machinery or may 
interact with it directly. 
Deber and coworkers have described systems with similar 
small perturbations in membrane environment or peptide se-
quence that can have large effects on structure of transmem-
brane spanning peptides and corresponding physiological ef-
fects [42,43]. Much work has been carried out investigating 
structure and function of the extracellular domains of the 
apoptotic receptors, but the current work examines a small 
fragment of the intracellular component of these receptors, 
sufficiently long to effect the apoptotic fate of neural cells. 
This work is of biological significance because of the demon-
strated role of the neurotrophin receptor in neural cell death. 
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